AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.AbbVie Inc. (ABBV) shares rose 1.07% to $256.10, outperforming competitors Johnson & Johnson, Pfizer, and Amgen during a favorable trading session where the S&P 500 and Dow Jones also gained. AbbVie closed 2.12% below its 52-week high of $261.64. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) advanced 1.07% to $256.10 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
AbbVie Inc. closed 2.12% below its 52-week high of $261.64, which the company achieved on July 2nd.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Pfizer Inc. (PFE) rose 0.77% to $24.94, and Amgen Inc. (AMGN) rose 0.57% to $366.24.
Trading volume (4.3 M) remained 2.8 million below its 50-day average volume of 7.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1631ET